Fesoterodine
Toviaz (fesoterodine) is a small molecule pharmaceutical. Fesoterodine was first approved as Toviaz on 2007-04-20. It is used to treat urge urinary incontinence in the USA. It has been approved in Europe to treat overactive urinary bladder. Toviaz's patents are valid until 2027-06-07 (FDA).
| Trade Name | Toviaz |
|---|---|
| Common Name | Fesoterodine |
| Indication | overactive urinary bladder, urge urinary incontinence |
| Drug Class |
